3SUR:F:F-iShares IV Public Limited Company - iShares MSCI USA SRI UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 1805

Change

-7.00 (-0.39)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

+0.08 (+0.30%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.05 (-0.09%)

USD 115.53B
SXR8:F iShares Core S&P 500 UCITS ETF..

N/A

USD 96.59B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.63B
SXRZ:F iShares VII PLC - iShares Nikk..

N/A

USD 57.94B
XDNY:F Xtrackers MSCI Japan ESG Scree..

N/A

USD 54.05B
VUAA:F Vanguard S&P 500 UCITS Acc

-0.07 (-0.07%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.18 (+0.19%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

+0.08 (+1.07%)

USD 40.74B
0ZC:F Zscaler Inc

-3.10 (-2.00%)

USD 37.92B

ETFs Containing 3SUR:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.77% 53% F 60% D-
Dividend Return 0.62% 3% F 5% F
Total Return 10.39% 52% F 53% F
Trailing 12 Months  
Capital Gain 21.60% 72% C 68% D+
Dividend Return 0.69% 3% F 4% F
Total Return 22.29% 70% C- 60% D-
Trailing 5 Years  
Capital Gain 76.86% 84% B 79% B-
Dividend Return 1.00% 31% F 2% F
Total Return 77.86% 85% B 67% D+
Average Annual (5 Year Horizon)  
Capital Gain 11.81% N/A N/A 73% C
Dividend Return 11.86% N/A N/A 66% D+
Total Return 0.04% N/A N/A 2% F
Risk Return Profile  
Volatility (Standard Deviation) 18.58% N/A N/A 67% D+
Risk Adjusted Return 63.81% N/A N/A 79% B-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike